Synchrotron X-ray Crystallography in Drug Discovery
We highlight a study conducted by the AstraZeneca team on synchrotron X-ray crystallography in drug discovery (Käck & Sjögren, 2024).
compound screening techniques
-
-
Crystallographic Fragment Screening In Drug Discovery: Background & Advantages
Technical developments have made crystallographic fragment screening the most effective method for screening fragment libraries. Here, we provide a brief overview of the method and its requirements.
-
Early Drug Discovery Services: Why Do You Need A CRO?
We discuss the the early drug discovery services market and highlight the integrated drug discovery CRO services provided by SARomics Biostructures.
-
WAC™ Fragment Screening Technology: Principles & Advantages
In this article, we discuss weak affinity chromatography (WAC™), the proprietary fragment screening technique jointly owned by SARomics Biostructures and Red Glead Discovery.
-
Protein-Ligand Interactions: Room Temperature or Cryo-Crystallography?
After many years of cryo-crystallography dominance, room-temperature X-ray crystallography using synchrotron radiation has returned. We discuss the application of room-temperature X-ray crystallography in drug design.
-
How to Choose A Library for Screening?
In this third post on structural biology and structure-based drug design we discuss methods and benefits of fragment-based lead discovery
